
hortly after 5 a.m., Teri Majewski marches purposefully into
Rush-Presbyterian-St. Luke's Medical Center in Chicago. Strongly
built and fit looking, the 34-year-old mother of two young
children seems too healthy to be in a hospital. But she checks
in at the day-surgery department and is summoned to an examining
room, from which she emerges a few minutes later in a baggy blue
hospital gown and the inevitable plastic bracelet. Suddenly, she
looks vulnerable. This morning Majewski is scheduled to undergo
a bone-marrow harvest, in which doctors will remove about a
quart of her marrow to be transplanted into a young patient
dying of leukemia. She has never met the patient, who lives in
Europe. They do not even know each other's names. They have been
brought together by a computer search, by the quirk of a few
shared genetic traits and, above all, by Majewski's kindness and
courage, her willingness to endure a painful procedure in the
hope of saving the life of a perfect stranger.
Bone-marrow transplantation is often the last hope for people
with devastating diseases: leukemia and other cancers, and
certain genetic disorders of the blood, immune system or
metabolism. Cure rates range from 20% to 80%, depending on the
disease, its stage and the degree of compatibility between the
donor's marrow and the recipient.
For the recipient, the process begins with massive doses of
chemotherapy or radiation, or both, to wipe out the disease. But
that treatment kills the patient's bone-marrow cells as well.
Without this spongy tissue at the core of many larger bones, a
person cannot live. Marrow contains the precious stem cells that
produce all the body's 30,000 trillion red blood cells, many of
its infection-fighting white cells and the platelets that are
essential for clotting.
| Page 1 | Page 2
| Page 3 |
|